Contract Research Organizations (CROs) play a critical role in the conduct of modern clinical trials. Pharmaceutical companies, biotechnology firms, medical device manufacturers, and academic institutions engage CROs to perform a wide range of activities related to the organization, coordination, and management of clinical research.

Delegating specific responsibilities to a specialized organization helps optimize resources, ensure compliance with international quality standards, and accelerate the execution of clinical research projects. However, even when certain responsibilities are delegated, the sponsor retains ultimate responsibility for the quality of the trial, the safety of participants, and the reliability of the data.

What Is a CRO?
A Contract Research Organization (CRO) is a specialized company that performs one or more functions related to the conduct of clinical trials under a contractual agreement with the sponsor.
The scope of delegated responsibilities may vary considerably. Some CROs provide individual services, such as clinical trial monitoring or statistical analysis, while others offer full-service project management, from protocol development through preparation of the regulatory submission dossier.
The activities of a CRO are governed by Good Clinical Practice (GCP), applicable national regulations, and the terms of the contract with the sponsor.

The Role of a CRO in Clinical Trials
The primary role of a CRO is to professionally perform the functions delegated by the sponsor while ensuring compliance with the approved study protocol, GCP requirements, and applicable regulatory standards.
A CRO provides operational support for the trial, coordinates communication among investigative sites, the sponsor, laboratories, and other vendors, and oversees the quality of study-related activities.
However, a CRO does not become the owner of the clinical trial and does not assume overall responsibility for its conduct.

Key Responsibilities of a CRO
Study Planning
During the initial stage of a clinical trial, a CRO may participate in developing the overall study strategy.
Key responsibilities include:

• developing the study implementation plan;
• estimating project timelines;
• preparing the study budget;
• selecting investigative sites;
• assessing study feasibility;
• participating in the preparation of study documentation.

At this stage, particular attention is given to identifying potential risks and developing appropriate risk mitigation strategies.
Preparation of Regulatory Documentation
One of the most important functions of a CRO is preparing documentation required to obtain regulatory approvals.
Depending on the project, the CRO may:

• prepare submission packages for Ethics Committees or Institutional Review Boards (IRBs);
• support submissions to regulatory authorities;
• monitor the approval process;
• coordinate amendments to study documentation;
• ensure that all study documents remain current and version-controlled.

Proper preparation of regulatory documentation helps avoid delays during study start-up.
Selection and Management of Investigative Sites
A CRO organizes the process of selecting healthcare institutions that will participate in the clinical trial.
Site evaluation typically includes assessment of:

• the experience of the investigative team;
• availability of the required equipment;
• patient recruitment capabilities;
• compliance with protocol requirements;
• availability of appropriate investigational product storage facilities;
• overall readiness of the site to conduct the study.

Once a site has been activated, the CRO provides operational support throughout the entire study.

Clinical Trial Monitoring
Clinical trial monitoring is one of the best-known functions of a CRO.
Clinical Research Associates (CRAs), or monitors:

• conduct site initiation, routine, and close-out visits;
• verify compliance with the study protocol;
• confirm that informed consent has been properly obtained;
• perform source data verification (SDV);
• review adverse event documentation;
• assess the quality of study documentation;
• monitor implementation of corrective actions.

Modern clinical trials often combine on-site and centralized monitoring as part of a risk-based monitoring approach.

Data Management
In many clinical trials, CROs are responsible for clinical data management.
Responsibilities include:

• developing electronic Case Report Forms (eCRFs);
• ensuring data completeness;
• managing data queries with investigative sites;
• performing database quality control;
• preparing datasets for statistical analysis;
• locking the clinical database after study completion.

High-quality data management reduces the risk of errors and improves the reliability of study results.

Pharmacovigilance
When delegated by the sponsor, a CRO performs pharmacovigilance activities related to safety monitoring.
Core responsibilities include:

• recording adverse events;
• processing Serious Adverse Event (SAE) reports;
• assessing the completeness of safety information;
• preparing safety reports;
• communicating with the sponsor, investigators, and regulatory authorities within the scope of delegated responsibilities.

Timely identification of safety signals is one of the most important components of clinical research.

Statistical Analysis and Reporting
Following study completion, a CRO may perform:

• statistical analysis of study results;
• preparation of statistical tables and figures;
• interpretation of results in collaboration with the sponsor;
• preparation of the Clinical Study Report (CSR);
• participation in the preparation of the regulatory submission dossier.

All statistical methods should be predefined in the study protocol and Statistical Analysis Plan (SAP).

Responsibilities of the CRO and the Sponsor
Despite the broad range of responsibilities assigned to a CRO, international GCP standards clearly define the allocation of accountability.
A CRO is responsible for the quality and proper execution of the functions formally delegated under the contractual agreement. The organization must comply with the study protocol, its quality management system, and all applicable regulatory requirements.
However, ultimate responsibility for the conduct of the clinical trial, protection of participants' rights, data quality, and compliance with applicable regulations always remains with the sponsor. Delegating responsibilities does not transfer overall accountability.
For this reason, sponsors should evaluate the qualifications of the CRO, oversee the performance of delegated activities, and ensure effective collaboration among all parties involved in the project.

Quality Management System Requirements for a CRO
To fulfill its responsibilities effectively, a CRO should maintain a robust Quality Management System (QMS).
The system typically includes:

• Standard Operating Procedures (SOPs);
• personnel training;
• internal quality control processes;
• document management;
• risk assessment;
• deviation management;
• implementation of Corrective and Preventive Actions (CAPA);
• preparation for audits and regulatory inspections.

An effective quality management system promotes compliance with GCP requirements and enhances the reliability of clinical trial results.

The Importance of CROs in Evidence-Based Medicine
The quality of a CRO's work has a direct impact on the reliability of clinical trial outcomes. Compliance with GCP, effective data management, robust monitoring, and timely identification of protocol deviations help reduce the risk of systematic errors and strengthen the quality of clinical evidence.
Nevertheless, the reliability of a clinical trial depends on more than the CRO's performance. A scientifically sound study protocol, qualified investigators, strict adherence to study procedures, and effective sponsor oversight are equally essential.


Contract Research Organizations are key participants in the modern clinical research ecosystem. They perform a broad range of activities, from study planning and regulatory support to clinical monitoring, data management, pharmacovigilance, and statistical analysis.
The effective performance of a CRO promotes compliance with international quality standards, enhances the reliability of clinical trial data, and improves the overall efficiency of study conduct. However, in accordance with ICH GCP requirements, delegating specific functions to a Contract Research Organization does not relieve the sponsor of ultimate responsibility for study quality, participant protection, and the reliability of clinical trial results.